Polypeptide capable of differentiating and maturing malignant cells into normal cells or capable of accelerating the formulation of erythroblasts
Patent Number: 5847078
Date of First Priority Issue: Wednesday July 2nd, 1986
Date Issued: Tuesday December 8th, 1998
Assignee: Unknown Assignee(s)
Inventors: Eto, Yuzuru (Yokohama-shi, Kanagawa-ken, JP); Tsuji, Tomoko (Kawasaki-shi, Kanagawa-ken, JP); Takano, Satoshi (Yokohama-shi, Kanagawa-ken, JP); Takezawa, Misako (Yokohama-shi, Kangawa-ken, JP); Yokogawa, Yasunori (Yamato-shi, Kanagawa-ken, JP); Shibai, Hi
Disclosed is a novel peptide that is useful for terminally differentiating leukemic cells. This peptide could be generally used for luekemia therapy, but should also be considered in combination with some other differentiation inducing agents such as retinoic acid.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking: